Announcement of TTY Biopharm's unaudited income information in August 2020

2020.9.10

Provided by: TTY BIOPHARM COMPANY LIMITED
SEQ_NO 1 Date of announcement 2020/09/10 Time of announcement 15:13:34
Subject Announcement of TTY Biopharm's unaudited income information in August 2020
Date of events 2020/09/10 To which item it meets paragraph 53
Statement 1.Date of occurrence of the event:2020/09/10
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $302,717 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $38,867 thousands, and a consolidated income before tax of $51,183 thousands in August 2020; net income attributed to stockholders of the company was $43,166 thousands; EPS is $0.17.
Year-to-date consolidated net sales was $2,610,415 thousands (in NT dollars; unaudited), a consolidated operating profit was $603,528 thousands and consolidated income before tax was $683,702 thousands until August 2020; year-to-date net income attributed to stockholders of the company was $541,478 thousands; EPS is $2.18.
6.Countermeasures:N/A
7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.
TOP